Investigation announced for Investors in shares of Liquidia Corporation (NASDAQ: LQDA) over potential Wrongdoing

An investigation on behalf of investors in Liquidia Corporation (NASDAQ: LQDA) shares over potential wrongdoing at Liquidia Corp.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Liquidia Corporation .

Investors who purchased shares of Liquidia Corporation (NASDAQ: LQDA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain Liquidia Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.

Morrisville, NC based Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company.

On November 25, 2020, Liquidia Corporation announced that the U.S. Food and Drug Administration (“FDA”) had issued a complete response letter (“CRL”) for the Company’s New Drug Application (“NDA”) for LIQ861 (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension. Specifically, Liquidia Corporation advised, among other things, that “[i]n the CRL, the FDA stated that it is unable to approve the NDA at this time,” citing “the need for additional information and clarification on chemistry, manufacturing and controls (CMC) data pertaining to the drug product and device biocompatibility.”

Shares of Liquidia Corporation (NASDAQ: LQDA) declined from $4.94 per share on November 11, 2020, to as low as $2.70 per share on November 25, 2020.

Those who purchased shares of Liquidia Corporation (NASDAQ: LQDA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.